Drugssquare, an international online medicines supplier & retailer illustrious for its expertise in the industry, is excited to announce the addition of [b]Geftistar 250 mg tablets[/b], manufactured by Hetero Labs Ltd. and Marketed by Lupin Ltd., in their broadspread of product List. Our broad and diverse portfolio of more than 7,500 products is available to customers of all types including retail and pharmacy establishments, wholesalers, medical institutions and physicians.

Geftistar , a Generic version of Iressa contains Gefitinib , a tyrosine kinase inhibitor used for the treatment of patients with metastatic [b]non-small cell lung cancer (NSCLC)[/b]. Geftistar 250 mg (Gefitinib) tablets blocks a protein called 'Epidermal Growth Factor Receptor' (EGFR) which is involved in the growth and spread of cancer cells.

Through innovation and a strong focus on customer service, Drugssquare will provide our customers with the distinct advantage of unparalleled product selection, competitive prices and the convenience of speedy home delivery. They take credit in ‘quality control’ and ‘quality assurance’ to offer their local and global customers improved health and wellness with their quality medicine.

[b]About Drugssquare[/b]

Drugssquare is a nationwide specialty Pharmacy dedicated to servicing patients with chronic illnesses requiring complex care. Their exceptional service and wide range of specialty products make them your partner of choice, while their experience, knowledge and commitment to patients make them your trusted partner in healthcare.

Find more information about how Drugssquare is shaping the future of health at [b]http://www.drugssquare.com[/b]
[b]E-mail: [email protected][/b]

[b]Source:[/b] https://www.prlog.org/12650533-drugssquare-online-pharmacy-announces-addition-of-geftistar-gefitinib-in-their-product-inventory.html